Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pura Ballester

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Revista Internacional De Andrologia|August 6, 2020
[Erectile dysfunction in patients with cardiovascular disease and the potential influence of genetic markers]Diego Ors, Ana Segura, Vicente Arrarte, et al.
Nutrients|November 27, 2025
Dietary Bioactive Compounds and Their Role in Allergy Prevention: A Comprehensive ReviewPilar Zafrilla, Pura Ballester, Desirée Victoria-Montesinos, et al.
Healthcare (Basel, Switzerland)|June 10, 2023
Self-Reported Medication Adherence Measured with Morisky Scales in Rare Disease Patients: A Systematic Review and Meta-AnalysisAna María García-Muñoz, Desirée Victoria-Montesinos, Begoña Cerdá, et al.
Frontiers in Pharmacology|June 16, 2023
Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differencesJavier Muriel, Jordi Barrachina, Guillermo Del Barco, et al.
Psychiatry Research|August 2, 2020
Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disabilityCristina Espadas, Pura Ballester, Ana Carolina Londoño, et al.
The Clinical Journal of Pain|March 10, 2020
Sex Bias and Genotype Influence on Opioid Safety Profile in Chronic Low Back PainCésar Margarit, Reyes Roca, María-Del-Mar Inda, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
<i>CYP2D6</i> Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype AnalysisPura Ballester, Cristina Espadas, Susana Almenara, et al.
Antioxidants (Basel, Switzerland)|July 29, 2025
Characterization, Antioxidant Capacity, and In Vitro Bioaccessibility of Ginger (<i>Zingiber officinale Roscoe</i>) in Different Pharmaceutical FormulationsLucía Plana, Javier Marhuenda, Raúl Arcusa, et al.
Autism Research : Official Journal of the International Society for Autism Research|October 15, 2021
The challenge of detecting adverse events in adults with autism spectrum disorder who have intellectual disabilityPura Ballester, Cristina Espadas, Ana C Londoño, et al.
Basic & Clinical Pharmacology & Toxicology|December 15, 2018
Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patientsJavier Muriel, César Margarit, Jordi Barrachina, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Revista Internacional De Andrologia|August 6, 2020
[Erectile dysfunction in patients with cardiovascular disease and the potential influence of genetic markers]Diego Ors, Ana Segura, Vicente Arrarte, et al.
Nutrients|November 27, 2025
Dietary Bioactive Compounds and Their Role in Allergy Prevention: A Comprehensive ReviewPilar Zafrilla, Pura Ballester, Desirée Victoria-Montesinos, et al.
Healthcare (Basel, Switzerland)|June 10, 2023
Self-Reported Medication Adherence Measured with Morisky Scales in Rare Disease Patients: A Systematic Review and Meta-AnalysisAna María García-Muñoz, Desirée Victoria-Montesinos, Begoña Cerdá, et al.
Frontiers in Pharmacology|June 16, 2023
Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differencesJavier Muriel, Jordi Barrachina, Guillermo Del Barco, et al.
Psychiatry Research|August 2, 2020
Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disabilityCristina Espadas, Pura Ballester, Ana Carolina Londoño, et al.
The Clinical Journal of Pain|March 10, 2020
Sex Bias and Genotype Influence on Opioid Safety Profile in Chronic Low Back PainCésar Margarit, Reyes Roca, María-Del-Mar Inda, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
<i>CYP2D6</i> Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype AnalysisPura Ballester, Cristina Espadas, Susana Almenara, et al.
Antioxidants (Basel, Switzerland)|July 29, 2025
Characterization, Antioxidant Capacity, and In Vitro Bioaccessibility of Ginger (<i>Zingiber officinale Roscoe</i>) in Different Pharmaceutical FormulationsLucía Plana, Javier Marhuenda, Raúl Arcusa, et al.
Autism Research : Official Journal of the International Society for Autism Research|October 15, 2021
The challenge of detecting adverse events in adults with autism spectrum disorder who have intellectual disabilityPura Ballester, Cristina Espadas, Ana C Londoño, et al.
Basic & Clinical Pharmacology & Toxicology|December 15, 2018
Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patientsJavier Muriel, César Margarit, Jordi Barrachina, et al.
Pageof 4